Glycemic And Blood Pressure Control In Type 2 Diabetes, In A Primary Care Unit: A Staged Management Strategy

Hospital de Clinicas de Porto Alegre

Status: Unknown

Conditions: Arterial Hypertension; Diabetes Mellitus

Treatments: Drug: Captopril; Drug: Amlodipine; Drug: Metformin; Drug: Hydrochlorothiazide; Drug: NPH insulin; Drug: Propranolol; Drug: Glybenclamide

Study type: Observational

Funder types: Other

Identifiers

NCT00935805

06260

Details and patient eligibility

About

The aim of this study is to to analyze if it is possible to reach the goals of HbA1c <7.0% and blood pressure <= 130/80 mm Hg in a cohort of patients with type 2 diabetes attending a primary care unit, using ony those resources available at the unit, and provided by the Brazilian National Health System. It is an open label, observational study, with a duration of 4-6 years. Patients attending a primary care outpatient facility will be sequentially included in the study provided they give consent. They will be followed on a monthly basis by a team of physicians and nurses. Glucose, A1c, Blood PRessure will be the outcomes.

Enrollment: 124 estimated patients

Sex: All

Ages: 30 to 85 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Type 2 diabetes mellitus (WHO)

Exclusion criteria

• Terminal disease (renal, cancer, heart failure)

Trial design

124 participants in 1 patient group

Treatment

Description:

124 patients attending the primary care unit included after formal consent.

Treatment:

Drug: Glybenclamide

Drug: Propranolol

Drug: NPH insulin

Drug: Hydrochlorothiazide

Drug: Metformin

Drug: Amlodipine

Drug: Captopril